Identification of Novel Scaffold Proteins for Improved Endogenous Engineering of Extracellular Vesicles

Extracellular vesicles (EVs) are gaining ground as next-generation drug delivery modalities. Genetic fusion of the protein of interest to a scaffold protein with high EV-sorting ability represents a robust cargo loading strategy. To address the paucity of such scaffold proteins we conducted a large-scale comparative study involving 244 candidate proteins. Their EV-sorting potential was evaluated using a simple but reliable assay that can distinguish intravesicular cargo proteins from surface and non-vesicular proteins. Notably, 24 proteins with conserved EV-sorting abilities across five types of producer cells were identified. Most of these are first to be reported including TSPAN2 and TSPAN3, which emerged as lead candidates, outperforming the well-known CD63 scaffold. Importantly, these engineered EVs show promise as delivery vehicles as demonstrated by in vitro and in vivo internalization studies with luminal cargo proteins as well as surface display of functional domains. The discovery of these novel scaffolds provides a new platform for EV-based engineering.

[1]  R. Vandenbroucke,et al.  Multimodal engineering of extracellular vesicles for efficient intracellular protein delivery , 2024, bioRxiv.

[2]  N. Kamei,et al.  Novel endogenous engineering platform for robust loading and delivery of functional mRNA by extracellular vesicles , 2023, bioRxiv.

[3]  Jeremy P Bost,et al.  Cell‐specific targeting of extracellular vesicles through engineering the glycocalyx , 2022, Journal of extracellular vesicles.

[4]  J. Nordin,et al.  Extracellular vesicles engineered to bind albumin demonstrate extended circulation time and lymph node accumulation in mouse models , 2022, Journal of extracellular vesicles.

[5]  Antje M Zickler,et al.  Identification of storage conditions stabilizing extracellular vesicles preparations , 2022, Journal of extracellular vesicles.

[6]  Lesley Cheng,et al.  Therapeutically harnessing extracellular vesicles , 2022, Nature Reviews Drug Discovery.

[7]  J. Lötvall,et al.  A brief history of nearly EV‐erything – The rise and rise of extracellular vesicles , 2021, Journal of extracellular vesicles.

[8]  R. Zain,et al.  Growth Media Conditions Influence the Secretion Route and Release Levels of Engineered Extracellular Vesicles , 2021, Advanced healthcare materials.

[9]  R. Vandenbroucke,et al.  Amelioration of systemic inflammation via the display of two different decoy protein receptors on extracellular vesicles , 2021, Nature Biomedical Engineering.

[10]  R. Carney,et al.  Tetraspanins are unevenly distributed across single extracellular vesicles and bias sensitivity to multiplexed cancer biomarkers , 2021, Journal of Nanobiotechnology.

[11]  G. Daaboul,et al.  Quantification of protein cargo loading into engineered extracellular vesicles at single‐vesicle and single‐molecule resolution , 2021, Journal of extracellular vesicles.

[12]  M. J. Wood,et al.  Extracellular vesicles as a next-generation drug delivery platform , 2021, Nature Nanotechnology.

[13]  V. Pascual,et al.  Extracellular vesicle– and particle-mediated communication shapes innate and adaptive immune responses , 2021, The Journal of experimental medicine.

[14]  P. Vader,et al.  Approaches to surface engineering of extracellular vesicles. , 2021, Advanced drug delivery reviews.

[15]  S. Kuroda,et al.  Real-Time Luminescence Assay for Cytoplasmic Cargo Delivery of Extracellular Vesicles. , 2021, Analytical chemistry.

[16]  M. Schulz-Siegmund,et al.  Nucleic acid delivery with extracellular vesicles. , 2021, Advanced drug delivery reviews.

[17]  Jing Huang,et al.  Small Extracellular Vesicles: A Novel Avenue for Cancer Management , 2021, Frontiers in Oncology.

[18]  R. Moniz,et al.  A versatile platform for generating engineered extracellular vesicles with defined therapeutic properties , 2021, Molecular therapy : the journal of the American Society of Gene Therapy.

[19]  Li Duan,et al.  Engineering exosomes for targeted drug delivery , 2021, Theranostics.

[20]  Deok‐Ho Kim,et al.  Engineering approaches for effective therapeutic applications based on extracellular vesicles. , 2020, Journal of controlled release : official journal of the Controlled Release Society.

[21]  V. D'Agostino,et al.  RNA packaging into extracellular vesicles: An orchestra of RNA‐binding proteins? , 2020, Journal of extracellular vesicles.

[22]  J. Jankovičová,et al.  Tetraspanins, More than Markers of Extracellular Vesicles in Reproduction , 2020, International journal of molecular sciences.

[23]  C. Maire,et al.  High‐Resolution Imaging Flow Cytometry Reveals Impact of Incubation Temperature on Labeling of Extracellular Vesicles with Antibodies , 2020, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[24]  B. Giepmans,et al.  Endocytosis of Extracellular Vesicles and Release of Their Cargo from Endosomes , 2020, ACS nano.

[25]  Chulhee Choi,et al.  Exosome-based delivery of super-repressor IκBα relieves sepsis-associated organ damage and mortality , 2020, Science Advances.

[26]  Y. Takakura,et al.  Therapeutic Application of Small Extracellular Vesicles (sEVs): Pharmaceutical and Pharmacokinetic Challenges. , 2020, Biological & pharmaceutical bulletin.

[27]  O. Nureki,et al.  Structural insights into tetraspanin CD9 function , 2020, Nature Communications.

[28]  Takeshi Noda,et al.  Extracellular nanovesicles for packaging of CRISPR-Cas9 protein and sgRNA to induce therapeutic exon skipping , 2020, Nature Communications.

[29]  J. Gruenberg,et al.  ALIX- and ESCRT-III–dependent sorting of tetraspanins to exosomes , 2020, The Journal of cell biology.

[30]  Raghu Kalluri,et al.  The biology, function, and biomedical applications of exosomes , 2020, Science.

[31]  Antje M Zickler,et al.  Quantification of extracellular vesicles in vitro and in vivo using sensitive bioluminescence imaging , 2020, Journal of extracellular vesicles.

[32]  Shi Hu,et al.  CAR exosomes derived from effector CAR-T cells have potent antitumour effects and low toxicity , 2019, Nature Communications.

[33]  C. Genoud,et al.  Systematic characterization of extracellular vesicle sorting domains and quantification at the single molecule – single vesicle level by fluorescence correlation spectroscopy and single particle imaging , 2019, Journal of extracellular vesicles.

[34]  J. Lötvall,et al.  Advances in therapeutic applications of extracellular vesicles , 2019, Science Translational Medicine.

[35]  Joshua A Welsh,et al.  Optimisation of imaging flow cytometry for the analysis of single extracellular vesicles by using fluorescence-tagged vesicles as biological reference material , 2019, Journal of extracellular vesicles.

[36]  M. Fabbri,et al.  Extracellular vesicles derived from natural killer cells use multiple cytotoxic proteins and killing mechanisms to target cancer cells , 2019, Journal of extracellular vesicles.

[37]  Jennifer C. Jones,et al.  Systematic Methodological Evaluation of a Multiplex Bead-Based Flow Cytometry Assay for Detection of Extracellular Vesicle Surface Signatures , 2018, Front. Immunol..

[38]  Imre Mäger,et al.  Extracellular Vesicle Heterogeneity: Subpopulations, Isolation Techniques, and Diverse Functions in Cancer Progression , 2018, Front. Immunol..

[39]  Willem Stoorvogel,et al.  Antigen Presentation by Extracellular Vesicles from Professional Antigen-Presenting Cells. , 2018, Annual review of immunology.

[40]  Martin Fussenegger,et al.  Designer exosomes produced by implanted cells intracerebrally deliver therapeutic cargo for Parkinson’s disease treatment , 2018, Nature Communications.

[41]  Graça Raposo,et al.  Shedding light on the cell biology of extracellular vesicles , 2018, Nature Reviews Molecular Cell Biology.

[42]  M. Wood,et al.  Reproducible and scalable purification of extracellular vesicles using combined bind-elute and size exclusion chromatography , 2017, Scientific Reports.

[43]  D. Meckes,et al.  Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers , 2016, Oncotarget.

[44]  Kwang Ryeol Lee,et al.  Exosome engineering for efficient intracellular delivery of soluble proteins using optically reversible protein–protein interaction module , 2016, Nature Communications.

[45]  A. Khvorova,et al.  High-resolution proteomic and lipidomic analysis of exosomes and microvesicles from different cell sources , 2016, Journal of extracellular vesicles.

[46]  Thomas Ritter,et al.  Mesenchymal Stem Cell-derived Extracellular Vesicles: Toward Cell-free Therapeutic Applications. , 2015, Molecular therapy : the journal of the American Society of Gene Therapy.

[47]  C. Futter,et al.  Hrs- and CD63-Dependent Competing Mechanisms Make Different Sized Endosomal Intraluminal Vesicles , 2014, Traffic.

[48]  R. Nieuwland,et al.  Single-step isolation of extracellular vesicles by size-exclusion chromatography , 2014, Journal of extracellular vesicles.

[49]  K. Braeckmans,et al.  Electroporation-induced siRNA precipitation obscures the efficiency of siRNA loading into extracellular vesicles. , 2013, Journal of controlled release : official journal of the Controlled Release Society.

[50]  Jie J. Zheng,et al.  Tetraspanins regulate the protrusive activities of cell membrane. , 2011, Biochemical and biophysical research communications.

[51]  P. Saftig,et al.  The tetraspanin CD63 regulates ESCRT-independent and -dependent endosomal sorting during melanogenesis. , 2011, Developmental cell.

[52]  Trairak Pisitkun,et al.  Large-scale proteomics and phosphoproteomics of urinary exosomes. , 2009, Journal of the American Society of Nephrology : JASN.

[53]  Petra Schwille,et al.  Ceramide Triggers Budding of Exosome Vesicles into Multivesicular Endosomes , 2008, Science.

[54]  P. Saftig,et al.  Tetraspanin 3: A central endocytic membrane component regulating the expression of ADAM10, presenilin and the amyloid precursor protein. , 2017, Biochimica et biophysica acta. Molecular cell research.